# Remegal Fixed Dose as Adjunctive Therapy in Patients With Partial Seizures

> **NCT01749046** · PHASE3 · COMPLETED · sponsor: **Valexfarm** · enrollment: 224 (actual)

## Conditions studied

- Epilepsy
- Simple Partial Seizures
- Complex Partial Seizures
- Partial Seizures With Secondary Generalization

## Interventions

- **DRUG:** Remegal

## Key facts

- **NCT ID:** NCT01749046
- **Lead sponsor:** Valexfarm
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2013-10
- **Final completion:** 2013-12
- **Target enrollment:** 224 (ACTUAL)
- **Last updated:** 2017-05-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01749046

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01749046, "Remegal Fixed Dose as Adjunctive Therapy in Patients With Partial Seizures". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01749046. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*